Add office photos
Employer?
Claim Account for FREE
MedPlus
3.6
based on 987 Reviews
Video summary
Company Overview
Company Locations
Working at MedPlus
Company Summary
MedPlus is one of India's leading healthcare companies with an ever-growing number of pharmacy stores, online pharmacy, path labs and optical services.
Overall Rating
3.6/5
based on 987 reviews
10% below
industry average
Critically rated for
Promotions, Work satisfaction, Salary
Work Policy
Work from office
93% employees reported
Monday to Saturday
48% employees reported
Strict timing
55% employees reported
Within city
44% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
42 employees reported
Health insurance
24 employees reported
Professional degree assistance
6 employees reported
Office cab/shuttle
6 employees reported
View all benefits
About MedPlus
Founded in2006 (19 yrs old)
India Employee Count10k-50k
Global Employee Count10k-50k
India HeadquartersHyderabad, India
Office Locations
Websitemedplusindia.com
Primary Industry
Other Industries
--
Are you managing MedPlus's employer brand? To edit company information,
claim this page for free
View in video summary
When Dr. Madhukar Gangadi came across a WHO report indicating that up to 30% of the fake medicines sold across the world came from India, he decided to study the Indian pharma retail market and sensed an opportunity to make a difference. He envisioned a company that would source all its medicines from reliable, big name suppliers, store medicines in optimal conditions to ensure their efficacy and take the risk out of buying medicines, give customers convenience to buy their medicines and value for their money.. The result was MedPlus.
Managing your company's employer brand?
Claim this Company Page for FREE
MedPlus Ratings
based on 987 reviews
Overall Rating
3.6/5
How AmbitionBox ratings work?
5
370
4
233
3
163
2
69
1
152
Category Ratings
3.6
Job security
3.6
Skill development
3.4
Work-life balance
3.2
Company culture
3.2
Salary
3.2
Work satisfaction
3.0
Promotions
MedPlus is rated 3.6 out of 5 stars on AmbitionBox, based on 987 company reviews.This rating reflects an average employee experience, indicating moderate satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at MedPlus
based on 859 reviews
3.7
Rated by 176 Women
Rated 3.9 for Job security and 3.8 for Skill development
3.6
Rated by 683 Men
Rated 3.6 for Job security and 3.6 for Skill development
Work Policy at MedPlus
based on 163 reviews in last 6 months
Work from office
93%
Hybrid
4%
Permanent work from home
3%
MedPlus Reviews
Top mentions in MedPlus Reviews
+ 5 more
Compare MedPlus with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 3.6/5 based on 987 reviews | 3.8/5 based on 1.7k reviews | 3.6/5 based on 541 reviews | 3.7/5 based on 967 reviews |
Highly Rated for | No highly rated category | Job security Skill development | No highly rated category | No highly rated category |
Critically Rated for | Promotions Salary Company culture | Promotions | Promotions Job security | Job security Promotions |
Primary Work Policy | Work from office 93% employees reported | Work from office 84% employees reported | Work from office 67% employees reported | Hybrid 54% employees reported |
Rating by Women Employees | 3.7 Good rated by 176 women | 4.0 Good rated by 313 women | 3.7 Good rated by 97 women | 3.8 Good rated by 154 women |
Rating by Men Employees | 3.6 Good rated by 683 men | 3.8 Good rated by 1.3k men | 3.6 Good rated by 418 men | 3.7 Good rated by 747 men |
Job security | 3.6 Good | 3.9 Good | 3.0 Average | 3.0 Average |
View more
MedPlus Salaries
MedPlus salaries have received with an average score of 3.2 out of 5 by 987 employees.
Pharmacist
(687 salaries)
Unlock
₹1 L/yr - ₹5 L/yr
Pharmacy Aide
(132 salaries)
Unlock
₹1 L/yr - ₹3.8 L/yr
Pharmacy Incharge
(119 salaries)
Unlock
₹1 L/yr - ₹5.5 L/yr
Pharmacy Assistant
(76 salaries)
Unlock
₹1 L/yr - ₹3.5 L/yr
Retail Pharmacist
(70 salaries)
Unlock
₹1.1 L/yr - ₹3.6 L/yr
Software Engineer
(61 salaries)
Unlock
₹4 L/yr - ₹14.5 L/yr
Customer Service Associate
(60 salaries)
Unlock
₹1 L/yr - ₹3.2 L/yr
Store Incharge
(51 salaries)
Unlock
₹1.1 L/yr - ₹3.1 L/yr
C.S.A
(49 salaries)
Unlock
₹1 L/yr - ₹3 L/yr
Supervisor
(39 salaries)
Unlock
₹1.3 L/yr - ₹5 L/yr
MedPlus Interview Questions
Interview questions by designation
Top MedPlus interview questions and answers
Get interview-ready with top interview questions
MedPlus Jobs
Popular Designations MedPlus Hires for
Current Openings
MedPlus News
View all
Stock Market Live Updates 13 March 2025: Stock to buy today: Divi’s Laboratories (₹5,665.55) – BUY
- Stock market updates on 13 March 2025: Positive news includes companies like BEML, NTPC Green, Carysil, Unimech Aerospace, Atishay Ltd, Nahar Industrial, Premier Explosives, Azad Engineering, Infosys, Polycab, NACL Industries, Waaree Renewable, Swelect Energy, Jubilant Pharmova, and Yatra Online.
- Neutral news involves companies like Bajaj Electricals Ltd, Jamna Auto, Beta Drugs, Dynamic Services, Medplus Health, Panasonic Carbon, Shantai Industries, DCAL, Manali Petrochemicals, NHPC, IndusInd Bank, Ola Electric, Zydus Lifesciences, Jaiprakash Associates, Satin Creditcare, Banking Stocks, ICICI Sec, and MTNL.
- Negative news includes Rattan India Power and D.S. Kulkarni Developers facing challenges.
- Divi's Laboratories is recommended for buying with potential growth and support at 200-DMA.
- Notable companies mentioned in the article are BEML, NTPC Green, Infosys, Jubilant Pharmova, and Divi's Laboratories.
- Economic calendar highlights and pre/post-market stock movements for various companies, including Futu Holdings Limited, Wheaton Precious Metals Corp, DocuSign, Inc, and Ulta Beauty, Inc, are also provided.
HinduBusinessLine | 13 Mar, 2025
Promoter pledge holdings in BSE-500 stocks decline to 0.84% in the December 2024: Kotak
- Promoter pledge holdings in BSE-500 stocks decline to 0.84% in the December 2024: Kotak
- Sun Pharma Advanced Research and UPL featured among companies with released pledged holdings to repay debts
- Nifty 50 constituents Apollo Hospitals, Asian Paints, IndusInd Bank, and JSW Steel had over 5% of pledged promoter holdings
- Highest pledged holdings in overall holdings found in Medplus Health Services, Chalet Hotels, and GMR Airports
HinduBusinessLine | 24 Feb, 2025
ONGC, Aptus Value, Medplus, Aarti Industries, Greenlam, Mahindra Lifespace, Neogen Q3 Review: HDFC Securities
- Brokerages give 'Buy' rating to Mahindra Lifespace, Neogen, and Medplus.
- They give 'Add' rating to Greenlam and Aarti Industries.
- They give 'Reduce' rating to Aptus Value, Sundaram Finance, and ONGC.
- HDFC Securities releases Q3 review of ONGC, Aptus Value, Medplus, Aarti Industries, Greenlam, Mahindra Lifespace, and Neogen.
Bloomberg Quint | 4 Feb, 2025
Healthtech startups net $1.13 Bn in 2024: Entrackr Report
- The Indian Healthtech sector is experiencing unprecedented growth, with the healthcare and life sciences sector experiencing a remarkable CAGR of 127% since 2016.
- The overall Indian Healthtech sector is poised to hit a potential market size of $50 billion by 2033, growing at an estimated CAGR of 26%.
- The Healthtech sector saw a strong recovery in 2024, with total capital raised surging to $1.13 billion, marking a significant rebound from previous downturns.
- Leading startups such as PharmEasy, Engrail, and NephroPlus played a crucial role in attracting investor interest, while PharmEasy, MedPlus, and Entero Healthcare emerged as revenue leaders.
- In 2024, growth and late-stage funding contributed $880.6 million across 22 deals, while early-stage startups secured $250.44 million through 72 deals.
- Pharmeasy led the funding list with $216 million in capital raised, followed by biotech firm Engrail and dialysis chain NephroPlus.
- The Healthtech sector witnessed 12 mergers and acquisitions (M&A) deals in 2024, signaling a trend toward strategic consolidation.
- Several prominent investors played a crucial role in shaping the Healthtech ecosystem in 2024, including Venture Catalysts, 360 One Asset Management, and Eight Roads Ventures.
- With the increasing demand for digital healthcare solutions, diagnostics, and AI-powered medical services, the sector is expected to see more IPO-bound companies in the coming years.
- The Healthcare and Healthtech sector has a long period of expansion ahead, and investors have their task cut out sorting through the many forms that will sizzle, only to fizzle out.
Entrackr | 31 Jan, 2025
Stocks To Watch Today: Jio Financial Services, Medplus Health, JK Tyre, HCLTech
- Jio Financial Services and BlackRock subscribed to Rs 5.85 crore shares of JV Jio BlackRock Asset Management for Rs 117 crore.
- Medplus Health's arm received three suspension orders of drug license for a store in Karnataka.
- Neuland Laboratories approved a capital expenditure of Rs 342 crore in two facilities.
- Other stocks to watch include JK Tyre Industries, Centum Electronics, HCL Technologies, Tanla Platforms, Vodafone Idea, Zydus Lifesciences, and Vedanta.
Bloomberg Quint | 22 Jan, 2025
Broker’s call: Medplus Health Services (Buy)
- Medplus Health Services Ltd (MHSL) is the second-largest player in India’s retail pharmacy segment with a robust network of 4,552 stores.
- MHSL has been expanding its presence in tier 2 and smaller cities, tapping into high-growth areas.
- Around 99% of MHSL's revenue comes from pharmacy operations, with the remaining from ancillary segments like diagnostic and optical.
- The company is expected to experience significant growth in revenue per store and improvements in EBITDA margins due to private-label products and matured stores.
HinduBusinessLine | 13 Jan, 2025
Stocks that will see action today: December 19
- ITC Ltd acquires stake in Oberoi and Hotel Leelaventure from Russell Credit Ltd.
- Usha Madhukar Chandurkar divests stake in Ipca Laboratories for ₹600 crore.
- Interarch Building Products forms strategic partnership with Jindal Steel & Power Ltd.
- MedPlus Health Services promoters execute Debenture Trust Deed for refinancing existing debt.
HinduBusinessLine | 19 Dec, 2024
Stocks that will see action today: November 19, 2024
- Delhi High Court rules in favour of Britannia Industries in trademark infringement case against Desi Bites Snack.
- Franklin Templeton MF, Invesco India, and Kotak Small Cap Fund acquire stake in MedPlus Health Services.
- Finance Ministry issues revised guidelines for capital restructuring by CPSEs regarding dividend payments.
- PG Electroplast signs agreement to manufacture electric vehicles of Spiro Mobility.
- MakeMyTrip to acquire Happay Expense Management platform from CRED.
- Reliance Power and Reliance Infrastructure reconstitute boards, appoint four senior officials.
- GVK Power & Infrastructure releases provisional list of prospective resolution applicants under CIRP.
HinduBusinessLine | 19 Nov, 2024
Azim Premji-Linked Fund Exits Medplus Health Services For Rs 482 Crore; Kotak MF, Invesco Among Buyers
- Premji Invest's affiliate, Pi Opportunities Fund - I, has sold its entire stake of 5.76% in Medplus Health Services for Rs 482 crore.
- Kotak Mahindra Mutual Fund and Invesco Mutual Fund are among the buyers, acquiring 2.56% each at Rs 700 per share.
- Franklin Templeton Mutual Fund, SBI Mutual Fund, and Morgan Stanley Asia Singapore also made purchases in the block deal.
- Medplus Health Services offers a wide range of products, including pharmaceuticals, wellness items, and FMCG products.
Bloomberg Quint | 18 Nov, 2024
MedPlus Bets On Private Labels To Drive Profitability Over Next Two Years
- MedPlus Health Services aims to grow its Ebitda by at least 1.2% in the next 6-8 quarters through increased contribution from private label products.
- The company plans to increase the volume contribution from private label products to 50% from the current 17%.
- The increase in private label share is expected to improve Ebitda margins by around 1% every quarter.
- Overall, MedPlus Health Services' revenue increased nearly 12% to Rs 1,576.2 crore in H1FY25.
Bloomberg Quint | 15 Nov, 2024
Powered by
Compare MedPlus with
Tata 1mg
3.6
HealthKart
4.0
Guardian Pharmacy
2.8
HealthifyMe
2.9
Practo
3.1
Portea Medical
3.7
Thyrocare Technologies
3.5
Reliance Retail
3.9
DMart
3.9
Future Group
4.2
Vishal Mega Mart
3.7
Shoppers Stop
4.1
Walmart
3.7
Landmark Group
4.0
Lifestyle
4.3
Reliance Trends
4.2
Future Retail
4.3
Metro Cash & Carry
4.1
Big Bazaar
4.2
Decathlon
3.8
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to MedPlus
Apollo Pharmacy
Retail
3.8
• 1.7k reviews
Netmeds.com
Internet
3.6
• 541 reviews
HealthKart
Internet, Consumer Electronics & Appliances
4.0
• 323 reviews
Guardian Pharmacy
Healthcare / Pharma
2.8
• 17 reviews
HealthifyMe
Internet
2.9
• 447 reviews
Practo
Financial Services, Internet, Fitness & Wellness, Healthcare
3.1
• 503 reviews
Portea Medical
Internet, Healthcare
3.7
• 378 reviews
Thyrocare Technologies
Beauty & Wellness, Healthcare
3.5
• 963 reviews
Reliance Retail
FMCG, Jewellery, Retail, Fashion & Textile, Beauty & Personal Care, Consumer Electronics & Appliances
3.9
• 22.7k reviews
DMart
Retail
3.9
• 4.6k reviews
MedPlus FAQs
When was MedPlus founded?
MedPlus was founded in 2006. The company has been operating for 19 years primarily in the Retail sector.
Where is the MedPlus headquarters located?
MedPlus is headquartered in Hyderabad and has an office in Hyderabad / Secunderabad
How many employees does MedPlus have in India?
MedPlus currently has more than 21,000+ employees in India. Healthcare & Life Sciences department appears to have the highest employee count in MedPlus based on the number of reviews submitted on AmbitionBox.
Does MedPlus have good work-life balance?
MedPlus has a work-life balance rating of 3.4 out of 5 based on 900+ employee reviews on AmbitionBox. 39% employees rated MedPlus 3 or below, while 61% employees rated it 4 or above for work-life balance. This rating suggests that while some employees recognize efforts towards work-life balance, there is scope for improvement based on employee feedback. We encourage you to read MedPlus work-life balance reviews for more details
Is MedPlus good for career growth?
Career growth at MedPlus is rated as moderate, with a promotions and appraisal rating of 3.0. 39% employees rated MedPlus 3 or below, while 61% employees rated it 4 or above on promotions/appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading MedPlus promotions/appraisals reviews for more detailed insights.
What are the cons of working in MedPlus?
Working at MedPlus does have some drawbacks that potential employees should consider. The company is poorly rated for promotions / appraisal, work satisfaction and salary & benefits, based on 900+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
75 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
